Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Tradeweb Markets
TW
$21.6B
| $10.6M | ﹤0.01% |
116,344
+21,867
| +23% | +$1.95M |
|
1477
Brixmor Property Group
BRX
$9.32B
| $10.6M | ﹤0.01% |
453,893
+221,057
| +95% | +$4.76M |
|
|
SUM
1478
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $10.5M | ﹤0.01% |
274,265
+172,825
| +170% | +$5.99M |
|
1479
Goodyear
GT
$1.85B
| $10.5M | ﹤0.01% |
734,824
-411,932
| -36% | -$5.47M |
|
|
AMED
1480
DELISTED
Amedisys
AMED
| $10.5M | ﹤0.01% |
110,631
-16,934
| -13% | -$1.58M |
|
1481
Casey's General Stores
CASY
$30.9B
| $10.5M | ﹤0.01% |
38,162
+16,282
| +74% | +$4.45M |
|
1482
Teva Pharmaceuticals
TEVA
$41.2B
| $10.5M | ﹤0.01% |
1,001,181
-117,021
| -10% | -$1.09M |
|
1483
Cheniere Energy
CQP
$31.3B
| $10.4M | ﹤0.01% |
209,848
+58,821
| +39% | +$3.28M |
|
1484
Synaptics
SYNA
$4.15B
| $10.4M | ﹤0.01% |
90,965
+54,454
| +149% | +$5.4M |
|
1485
PUT
Boston Beer
SAM
$1.92B
| $10.4M | ﹤0.01% |
+30,000
| New | +$10.5M |
|
1486
Insmed
INSM
$28.6B
| $10.4M | ﹤0.01% |
334,529
+162,728
| +95% | +$4.22M |
|
|
PCH
1487
DELISTED
PotlatchDeltic
PCH
| $10.4M | ﹤0.01% |
210,826
+144,213
| +216% | +$6.6M |
|
1488
Eagle Materials
EXP
$6.57B
| $10.3M | ﹤0.01% |
51,009
+8,822
| +21% | +$1.55M |
|
|
SKX
1489
DELISTED
Skechers
SKX
| $10.3M | ﹤0.01% |
165,832
-16,757
| -9% | -$903K |
|
1490
Five Below
FIVE
$13.5B
| $10.3M | ﹤0.01% |
48,457
-120,062
| -71% | -$22M |
|
1491
Keros Therapeutics
KROS
$221M
| $10.3M | ﹤0.01% |
259,760
+210,249
| +425% | +$6.59M |
|
|
FOLD
1492
DELISTED
Amicus Therapeutics
FOLD
| $10.3M | ﹤0.01% |
727,775
+315,339
| +76% | +$3.58M |
|
1493
Sanofi
SNY
$104B
| $10.3M | ﹤0.01% |
207,069
+20,876
| +11% | +$1.02M |
|
1494
PUT
TripAdvisor
TRIP
$1.26B
| $10.3M | ﹤0.01% |
477,300
+177,300
| +59% | +$3.11M |
|
1495
CALL
Warner Bros
WBD
$67.1B
| $10.2M | ﹤0.01% |
900,000
-900,000
| -50% | -$9.71M |
|
1496
iShares Silver Trust
SLV
$30.7B
| $10.2M | ﹤0.01% |
470,118
+42,482
| +10% | +$904K |
|
1497
Lyft
LYFT
$6.63B
| $10.2M | ﹤0.01% |
682,067
+212,123
| +45% | +$2.47M |
|
1498
Flowserve
FLS
$10.2B
| $10.2M | ﹤0.01% |
247,902
+106,079
| +75% | +$4.08M |
|
1499
Haemonetics
HAE
$4B
| $10.2M | ﹤0.01% |
118,899
+81,303
| +216% | +$7.03M |
|
1500
Revolution Medicines
RVMD
$44B
| $10.1M | ﹤0.01% |
353,785
+125,124
| +55% | +$3.01M |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.